Table 1. Summary of baseline characteristics in patients with Alzheimer’s disease (AD) and non-demented controls (ND).
| Continuous data reported as mean (Standard Deviation) | AD (N=50) | ND (N=50) |
|---|---|---|
| Age, years | 77.5 (6.9) | 74.0 (8.0) |
| Gender, male/female | 28/22 | 22/28 |
| Mini-mental State Examination score | 19.9 (4.8) | NA |
| Haemoglobin, g/L | 139.1 (10.6) | 137.9 (10.4) |
| Leukocytes, 109/L | 6.75 (1.78) | 6.28 (1.67) |
| Lymphocytes, 109/L | 1.95 (0.89) | 1.88 (0.61) |
| C-reactive protein, mg/L | 3.59 (7.05) | 3.18 (4.84) |
| Interleukin-6, ng/L | 2.24 (2.94) | 2.23 (3.08) |
| APOE ε4 allele carriers, hetero-/homozygote | 28/4 | 16/2 |
| CMV IgG positive | 84% (n=42) | 78% (n=39) |
| HLA-A02 positive | 60% (n=30) | 70% (n=36) |
| HLA-A02 and CMV IgG positive | 52% (n=26) | 60% (n=30) |
| HLA-A01/A02/A24/B07/B08/B35 positive | 94% (n=47) | 90% (n=45) |
| HLA-A01/A02/A24/B07/B08/B35 positive and CMV IgG positive | 78% (n=39) | 72% (n=36) |
NA = Not Available